Asthma: Time to confront some inconvenient truths

Respirology

Volumn 15, Issue 2, 2010, Pages 194-201

  Hancox, Robert J ^a   Le Souëf, Peter N ^c   Anderson, Gary P ^d   Reddel, Helen K ^e   Chang, Anne B ^f,g   Beasley, Richard ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Asthma; Genetics; Guideline; Management; Vaccine

Indexed keywords

ASTHMA; CELL THERAPY; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; DISEASE COURSE; DRUG SAFETY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOTHERAPY; MEDICAL RESEARCH; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; VACCINATION;

ASTHMA; DRUG THERAPY; GUIDELINE ADHERENCE; HUMANS; PRIMARY HEALTH CARE; PUBLIC HEALTH; RISK FACTORS;

EID: 76249106437     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2009.01700.x     Document Type: Review

References (93)

1. Wijesinghe M, Weatherall M, Perrin K et al. International trends in asthma mortality rates in the 5-34 year age group: a call for closer surveillance. Chest 2009 135: 1045 1049.
2. Martinez FD. Genes, environments, development and asthma: a reappraisal. Eur. Respir. J. 2007 29: 179 184.
3. Martinez FD, Wright AL, Taussig LM et al. Asthma and wheezing in the first six years of life. N. Engl. J. Med. 1995 332: 133 138.
4. Sly PD, Boner AL, Bjorksten B et al. Early identification of atopy in the prediction of persistent asthma in children. Lancet 2008 372: 1100 1106.
5. Corvalan C, Amigo H, Bustos P et al. Socioeconomic risk factors for asthma in Chilean young adults. Am. J. Public Health 2005 95: 1375 1381.
6. Asthma Management Handbook, 6th edn. National Asthma Council Australia, Melbourne, 2006.
7. Sears MR, Greene JM, Willan AR et al. Long-term relation between breastfeeding and development of atopy and asthma in children and young adults: a longitudinal study. Lancet 2002 360: 901 907.
8. Wright AL, Holberg CJ, Taussig LM et al. Factors influencing the relation of infant feeding to asthma and recurrent wheeze in childhood. Thorax 2001 56: 192 197.
9. Kramer MS, Matush L, Vanilovich I et al. Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: cluster randomised trial. BMJ 2007 335: 815.
10. Mihrshahi S, Ampon R, Webb K et al. The association between infant feeding practices and subsequent atopy among children with a family history of asthma. Clin. Exp. Allergy 2007 37: 671 679.
11. Greer FR, Sicherer SH, Burks AW, The Committee on N, Section on A, Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics 2008 121: 183 191.
12. Hancox RJ, Welch D, Poulton R et al. Cigarette smoking and allergic sensitization: a 32-year population-based cohort study. J. Allergy Clin. Immunol. 2008 121: 38 42, e3.
13. von Mutius E, Martinez FD, Fritzsch C et al. Prevalence of asthma and atopy in two areas of West and East Germany. Am. J. Respir. Crit. Care Med. 1994 149: 358 364.
14. Farquhar H, Crane J, Mitchell EA et al. The acetaminophen and asthma hypothesis 10 years on: a case to answer. J. Allergy Clin. Immunol. 2009 124: 649 651.
15. Prymula R, Siegrist CA, Chlibek R et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009 374: 1339 1350.
16. Strachan DP. Family size, infection and atopy: the first decade of the 'hygiene hypothesis'. Thorax 2000 55 (Suppl. 1 S2 10.
17. Mandhane PJ, Sears MR, Poulton R et al. Cats and dogs and the risk of atopy in childhood and adulthood. J. Allergy Clin. Immunol. 2009 124: 745 750, e4.
18. Cooper PJ. Interactions between helminth parasites and allergy. Curr. Opin. Allergy Clin. Immunol. 2009 9: 29 37.
19. Douwes J, Pearce N. Commentary: the end of the hygiene hypothesis? Int. J. Epidemiol. 2008 37: 570 572.
20. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun. 2006 7: 95 100.
21. Zhang G, Goldblatt J, Lesouef P. The era of genome-wide association studies: opportunities and challenges for asthma genetics. J. Hum. Genet. 2009 54: 624 628.
22. Rogers AJ, Raby BA, Lasky-Su JA et al. Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. Am. J. Respir. Crit. Care Med. 2009 179: 1084 1090.
23. Zhang G, Khoo SK, Laatikainen T et al. Opposite gene by environment interactions in Karelia for CD14 and CC16 single nucleotide polymorphisms and allergy. Allergy 2009 64: 1333 1341.
24. Candelaria PV, Backer V, Khoo SK et al. The importance of environment on respiratory genotype/phenotype relationships in the Inuit. Allergy 2009 doi:10.1111/j.1398-9995.2009.02145.x.
25. Laing IA, Le Souëf PN. Association studies in asthma. In: Weiss ST, Postma D (eds) Genetics of Asthma and COPD. Marcel Dekker, New York, 2007 239 272.
26. Hall IP, Sayers I. Pharmacogenetics and asthma: false hope or new dawn? Eur. Respir. J. 2007 29: 1239 1245.
27. Platts-Mills T, Vaughan J, Squillace S et al. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001 357: 752 756. (Pubitemid 32217683)
28. Gern JE. Viral respiratory infection and the link to asthma. Pediatr. Infect. Dis. J. 2008 27 (10 Suppl S97 103.
29. Johnston SL. Innate immunity in the pathogenesis of virus-induced asthma exacerbations. Proc. Am. Thorac. Soc. 2007 4: 267 270.
30. Tan GH, Su JM, Wang CC et al. A recombinant DNA plasmid encoding the human interleukin-5 breaks immunological tolerance and inhibits airway inflammation in a murine model of asthma. Int. Arch. Allergy Immunol. 2008 145: 313 323.
31. Bousquet J, Lockey R, Malling HJ et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. 1998 81: 401 405.
32. Abramson MJ, Puy RM, Weiner JM. Allergen immunotherapy for asthma. Cochrane Database Syst. Rev. 2003 4 CD001186.
33. Calamita Z, Saconato H, Pela AB et al. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 2006 61: 1162 1172.
34. Jacobsen L, Niggemann B, Dreborg S et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007 62: 943 948.
35. Thorburn AN, Hansbro PM, Gibson PG. Pneumococcal vaccines for allergic airways diseases. Expert Opin. Biol. Ther. 2009 9: 621 629.
36. Hufnagl K, Winkler B, Focke M et al. Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J. Allergy Clin. Immunol. 2005 116: 370 376.
37. Wiedermann U. Prophylaxis and therapy of allergy by mucosal tolerance induction with recombinant allergens or allergen constructs. Curr. Drug Targets Inflamm. Allergy 2005 4: 577 583.
38. Jin H, Kang Y, Zhao L et al. Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines. J. Immunol. 2008 180: 5360 5372.
39. Jarman ER, Lamb JR. Reversal of established CD4+ type 2 T helper-mediated allergic airway inflammation and eosinophilia by therapeutic treatment with DNA vaccines limits progression towards chronic inflammation and remodelling. Immunology 2004 112: 631 642.
40. Suzuki K, Kaminuma O, Yang L et al. Development of transgenic rice expressing mite antigen for a new concept of immunotherapy. Int. Arch. Allergy Immunol. 2009 149 (Suppl. 1 21 4.
41. Agrawal S, Kandimalla ER. Synthetic agonists of Toll-like receptors 7, 8 and 9. Biochem. Soc. Trans. 2007 35: 1461 1467.
42. Jurk M, Vollmer J. Therapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulation. BioDrugs 2007 21: 387 401.
43. Gauvreau GM, Hessel EM, Boulet LP et al. Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses. Am. J. Respir. Crit. Care Med. 2006 174: 15 20.
44. Creticos PS, Schroeder JT, Hamilton RG et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 2006 355: 1445 1455.
45. Kuipers H, Lambrecht BN. Modification of dendritic cell function as a tool to prevent and treat allergic asthma. Vaccine 2005 23: 4577 4588.
46. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 2008 372: 1107 1119.
47. Bel EH. Clinical phenotypes of asthma. Curr. Opin. Pulm. Med. 2004 10: 44 50.
48. Haldar P, Pavord ID, Shaw DE et al. Cluster analysis and clinical asthma phenotypes. Am. J. Resp. Crit. Care Med. 2008 178: 218 224.
49. Suissa S, Ernst P, Benayoun S et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N. Engl. J. Med. 2000 343: 332 336.
50. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax 2002 57: 880 884.
51. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004 59: 469 478.
52. Ait-Khaled N, Enarson DA, Bencharif N et al. Treatment outcome of asthma after one year follow-up in health centres of several developing countries. Int. J. Tuberc. Lung Dis. 2006 10: 911 916. (Pubitemid 44197853)
53. Jenkins CR. Spirometry performance in primary care: the problem, and possible solutions. Prim. Care Respir. J. 2009 18: 128 129.
54. Aaron SD, Vandemheen KL, Boulet L-P et al. Overdiagnosis of asthma in obese and nonobese adults. CMAJ 2008 179: 1121 1131.
55. Australian Centre for Asthma Monitoring. Asthma in Australia 2008. AIHW Asthma Series 3 2008; Cat. no. ACM 14. AIHW, Canberra, 2008.
56. Diette GB, Patino CM, Merriman B et al. Patient factors that physicians use to assign asthma treatment. Arch. Intern. Med. 2007 167: 1360 1366.
57. Weatherall M, Clay J, James K et al. Dose-response relationship of inhaled corticosteroids and cataracts: a systematic review and meta-analysis. Respirology 2009 14: 983 990.
58. Grimshaw JM, Shirran L, Thomas R et al. Changing provider behavior: an overview of systematic reviews of interventions. Med. Care 2001 39: II2 45.
59. van Beerendonk I, Mesters I, Mudde AN et al. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J. Asthma 1998 35: 273 279.
60. Guidry GG, Brown WD, Stogner SW et al. Incorrect use of metered dose inhalers by medical personnel. Chest 1992 101: 31 3.
61. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur. Respir. J. 2002 19: 246 251.
62. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir. Care 2005 50: 1360 1374.
63. Basheti IA, Reddel HK, Armour CL et al. Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists. J. Allergy Clin. Immunol. 2007 119: 1537 1538.
64. Basheti IA, Armour CL, Reddel HK et al. Long-term maintenance of pharmacists' inhaler technique: applying focused educational tools. Am. J. Pharm. Educ. 2009 73: 1 8.
65. Williams LK, Pladevall M, Xi H et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J. Allergy Clin. Immunol. 2004 114: 1288 1293.
66. Menckeberg TT, Bouvy ML, Bracke M et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J. Psychosom. Res. 2008 64: 47 54.
67. Hynd A, Roughead EE, Preen DB et al. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol. Drug Saf. 2008 17: 1091 1099.
68. Rand CS. Non-adherence with asthma therapy: more than just forgetting. J. Pediatr. 2005 146: 157 159.
69. Haynes RB, Ackloo E, Sahota N et al. Interventions for enhancing medication adherence. Cochrane Database Syst. Rev. 2009 3 CD000011.
70. Charles T, Quinn D, Weatherall M et al. An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. J. Allergy Clin. Immunol. 2007 119: 811 816.
71. Papi A, Caramori G, Adcock IM et al. Rescue treatment in asthma. More than as-needed bronchodilation. Chest 2009 135: 1628 1633.
72. Ampon RD, Reddel HK, Correll PK et al. Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease. Med. J. Aust. 2009 191: 319 323.
73. Martinez FD. Safety of long-acting beta-agonists-an urgent need to clear the air. N. Engl. J. Med. 2005 353: 2637 2639.
74. Beasley R, Martinez F, Hackshaw A et al. Safety of long-acting beta agonists: urgent need to clear the air remains. Eur. Respir. J. 2009 33: 3 5.
75. Krishnan JA, Riekert KA, McCoy JV et al. Corticosteroid use after hospital discharge among high-risk adult with asthma. Am. J. Respir. Crit. Care Med. 2004 170: 1281 1285.
76. Stoloff SW, Stempel DA, Meyer J et al. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J. Allergy Clin. Immunol. 2004 113: 245 251.
77. Stempel DA, Stoloff SW, Carranza Rosenzweig JR et al. Adherence to asthma controller medication regimens. Respir. Med. 2005 99: 1263 1267.
78. Sovani MP, Whale CI, Oborne J et al. Poor adherence with inhaled corticosteroids for asthma: can using a single inhaler containing budesonide and formoterol help? Br. J. Gen. Pract. 2008 58: 37 43.
79. Weatherall M, Wijesinghe M, Perrin K et al. The risk of mortality with salmeterol treatment: the effect of concomitant inhaled corticosteroid therapy. Thorax 2010 65: 39 43.
80. Sears MR, Ottosson A, Radner F et al. Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials. Eur. Respir. J. 2009 33: 21 32.
81. Wijesinghe M, Weatherall M, Perrin K et al. Risk of mortality associated with formoterol: a systematic review and meta-analysis. Eur. Respir. J. 2009 34: 803 811.
82. Kramer JM. Balancing the benefits and risks of inhaled long-acting beta-agonists-the influence of values. N. Engl. J. Med. 2009 360: 1592 1595.
83. DiSantostefano RL, Davis KJ, Yancey S et al. Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid-and salmeterol-containing products. Ann. Allergy Asthma Immunol. 2008 100: 558 565.
84. Wijesinghe M, Perrin K, Harwood M et al. The risk of asthma mortality with inhaled long acting β-agonists. Postgrad. Med. J. 2008 84: 467 472.
85. Drazen JM, O'Byrne PM. Risks of long-acting beta-agonists in achieving asthma control. N. Engl. J. Med. 2009 360: 1671 1672.
86. Preiser JC, Ledoux D. The use of protocols for nutritional support is definitely needed in the intensive care unit. Crit. Care Med. 2004 32: 2354 2355.
87. Burgers JS, Grol RP, Zaat JO et al. Characteristics of effective clinical guidelines for general practice. Br. J. Gen. Pract. 2003 53: 15 19.
88. Cabana MD, Rand CS, Powe NR et al. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999 282: 1458 1465.
89. Ploeg J, Davies B, Edwards N et al. Factors influencing best-practice guideline implementation: lessons learned from administrators, nursing staff, and project leaders. Worldviews Evid. Based Nurs. 2007 4: 210 219.
90. Grimshaw JM, Thomas RE, MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol. Assess. 2004 8: iii 72.
91. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008 336: 924 926.
92. Whorlow K. A decade of asthma management in Australia Accessed 25 Sep 2009.] Available from URL: http://www.nationalasthma.orgau/content/view/370/467/
93. Weinberger M. Seventeen years of asthma guidelines: why hasn't the outcome improved for children? J. Pediatr. 2009 154: 786 788.